Clal Biotechnology Industries (XTAE:CBI) Scaled Net Operating Assets : 0.61 (As of Jun. 2024)

View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries Scaled Net Operating Assets?

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Clal Biotechnology Industries's operating assets for the quarter that ended in Jun. 2024 was ₪97.78 Mil. Clal Biotechnology Industries's operating liabilities for the quarter that ended in Jun. 2024 was ₪1.25 Mil. Clal Biotechnology Industries's Total Assets for the quarter that ended in Dec. 2023 was ₪158.39 Mil. Therefore, Clal Biotechnology Industries's scaled net operating assets (SNOA) for the quarter that ended in Jun. 2024 was 0.61.

Clal Biotechnology Industries Scaled Net Operating Assets Historical Data

The historical data trend for Clal Biotechnology Industries's Scaled Net Operating Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries Scaled Net Operating Assets Chart

Clal Biotechnology Industries Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Scaled Net Operating Assets

Get a 7-Day Free Trial

0.39

0.54

0.48

0.38

0.79

Clal Biotechnology Industries Semi-Annual Data
	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24
Scaled Net Operating Assets	Get a 7-Day Free Trial															0.66	0.38	0.82	0.74	0.61

Competitive Comparison of Clal Biotechnology Industries's Scaled Net Operating Assets

For the Biotechnology subindustry, Clal Biotechnology Industries's Scaled Net Operating Assets, along with its competitors' market caps and Scaled Net Operating Assets data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Clal Biotechnology Industries's Scaled Net Operating Assets Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clal Biotechnology Industries's Scaled Net Operating Assets distribution charts can be found below:

* The bar in red indicates where Clal Biotechnology Industries's Scaled Net Operating Assets falls into.

Clal Biotechnology Industries Scaled Net Operating Assets Calculation

Scaled Net Operating Assets (SNOA) is calculated as the difference between operating assets and operating liabilities, scaled by lagged total assets.

Clal Biotechnology Industries's Scaled Net Operating Assets (SNOA) for the fiscal year that ended in Dec. 2023 is calculated as

	Scaled Net Operating Assets (SNOA)		(A: Dec. 2023 )
=	(Operating Assets (A: Dec. 2023 )	-	Operating Liabilities (A: Dec. 2023 ))	/	Total Assets (A: Dec. 2022 )
=	(145.03	-	1.221)	/	182.69
=	0.79

where

	Operating Assets		(A: Dec. 2023 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	158.386	-	13.356
=	145.03

	Operating Liabilities		(A: Dec. 2023 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	36.978	-	30.316	-	5.441
=	1.221

Clal Biotechnology Industries's Scaled Net Operating Assets (SNOA) for the quarter that ended in Jun. 2024 is calculated as

	Scaled Net Operating Assets (SNOA)		(Q: Jun. 2024 )
=	(Operating Assets (Q: Jun. 2024 )	-	Operating Liabilities (Q: Jun. 2024 ))	/	Total Assets (Q: Dec. 2023 )
=	(97.781	-	1.248)	/	158.386
=	0.61

where

	Operating Assets		(Q: Jun. 2024 )
=	Total Assets	-	Cash, Cash Equivalents, Marketable Securities
=	107.32	-	9.539
=	97.781

	Operating Liabilities		(Q: Jun. 2024 )
=	Total Liabilities	-	Long-Term Debt & Capital Lease Obligation	-	Short-Term Debt & Capital Lease Obligation
=	24.38	-	19.677	-	3.455
=	1.248

Clal Biotechnology Industries Scaled Net Operating Assets Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's Scaled Net Operating Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Clal Biotechnology Industries Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » Scaled Net Operating Assets

Comparable Companies

Traded in Other Exchanges

N/A

Address

Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023

Website

http://www.cbi.co.il

Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.